Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection

Clinical Immunology and Immunopathology

Volumn 61, Issue 2 PART 1, 1991, Pages 236-248

  Ward, Brian J ^a   Johnson, Richard T ^c   Vaisberg, Abraham ^a   Jauregui, Enrique ^b   Griffin, Diane E ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^c INSTITUTO NACIONAL DE SALUD DEL NIÑO   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 2; TUMOR NECROSIS FACTOR;

ARTICLE; CELL CULTURE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; MEASLES VIRUS; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS INFECTION;

CD4-CD8 RATIO; CHILD; CHILD, PRESCHOOL; CYTOKINES; HUMAN; INFANT; INTERFERON TYPE II; INTERLEUKIN-1; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; MEASLES; RECEPTORS, INTERLEUKIN-2; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR NECROSIS FACTOR;

EID: 0026002984     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-1229(05)80027-3     Document Type: Article

References (47)

1. Cellular immune responses during complicated and uncomplicated measles virus infections of man
2. Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infection
3. Acute measles in patients with and without neurologic involvement: Distribution of measles virus antigen and RNA
4. Immune activation during measles: Interferon-γ and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease
5. Immune activation in measles
6. Dissociation of lymphokine production and blastogenesis in children with measles infection
7. T-lymphocyte subpopulations in relation to immunosuppression in measles and varicella
8. Spontaneous proliferation of peripheral mononuclear cells in natural measles virus infection: Identification of dividing cells and correlation with mitogen responsiveness
9. Peripheral blood mononuclear cells during measles virus infection: Cell surface phenotypes and evidence for activation
10. Cellular cytotoxicity to measles virus during natural measles infection
11. Severe measles: Some unanswered questions
12. Transient disappearance of immunologic disorders and remission after intercurrent measles infections in children with chronic idiopathic thrombocytopenic purpura
13. Prospective study of the magnitude and duration of changes in tuberculin reactivity during complicated and uncomplicated measles
14. Cell mediated immunity during natural measles virus infection
15. Natural killer cell activity during measles
16. Decreased oxygen radical generation by neutrophils from patients with measles presumably owing to activation of suppressor T cells
17. Inhibition of lymphocyte stimulation by measles virus
18. Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production
19. Defective production of interleukin-1 and interleukin-2 in patients with systemic lupus erythematosis (SLE)
20. Role of interleukin-2 (IL-2) and IL-2 receptor expression in the proliferative defect observed in mitogen-stimulated lymphocytes from patients with gliomas
21. Patients with condyloma accuminatum exhibit decreased interleukin-2 and interferon-gamma production and decreased natural killer activity
22. Production of and in vitro response to IL-2 in AIDS
23. Defective gamma-interferon production in leprosy
24. T cell subpopulations, expression of interleukin-2 receptor and production of interleukin-2 and gamma-interferon-in human american cutaneous leishmaniasis
25. Secretory products of macrophages
26. Circulating interferon after measles vaccination
27. Cell-mediated immunity in measles using the leukocyte migration test
28. Interferon status after measles virus infection
29. More exact quantification of interleukin-2 production by addition of anti-Tac monoclonal antibody to cultures of stimulated lymphocytes
30. Interleukin-2. Inception, impact and implications
31. Interferon-γ: Producing cells, activation stimuli, and molecular genetic regulation
32. + T helper cells differing in kinetics and capacities to produce interleukin-2 and interferon-gamma can be defined by the Leu-18 and UCHL1 monoclonal antibodies
33. + cells become refractory to interleukin-2
34. The induction of T cell unresponsiveness by rapid modulation of CD3
35. Correction of interleukin-2 production in patients with systemic lupus erythematosis by removal of spontaneously activated suppressor cells
36. Immunosuppression in viral infections
37. Regulation of human T cell production of interleukin-2 by Leu 11 (CD16) positive large granular lymphocytes
38. Interleukin-1
39. Tumor necrosis factor-α/cachectin is a growth factor for thymocytes. Synergistic interactions with other cytokines
40. Enhancement of antigen- and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-α
41. Enhancement of human B cell proliferation and differentiation by tumor necrosis factor and interleukin-1
42. Effect of interleukin-2 and mitogens on the production of tumor necrosis factor α and β
43. Cachectin: more than a tumor necrosis factor
44. Mechanisms and significance of the mitogenic and antiviral actions of TNF
45. Interleukin 4/B cell stimulatory factor 1: 1 lymphokine, many functions
46. IL-6 and IL-1 synergize to stimulate IL-2 production and proliferation of peripheral T cells
47. Interleukin 7: effects on early events in lymphopoiesis